agentsclimarketplace

Cc cover letter

Skill brycewang-stanford/Awesome-Journal-Skills/Cancer-Cell-Skills/skills/cc-cover-letter

Journal-specific Claude Code/Codex skill packs covering mainstream journals — AER, QJE, Nature, Cell, 管理世界, 经济研究 & 200+ more — your fast track to getting published. | 覆盖主流期刊的 Claude Code/Codex 期刊技能包,从选题、识别策略到表格规范与审稿回复全流程,助你快速发论文。

Install
npx -y skills add brycewang-stanford/Awesome-Journal-Skills --skill cc-cover-letter

Assembled from the repository path, not quoted from the project. Check it against their README if it does not work.

What its author says it does

Copied from the file, not written here

Use when drafting the cover letter (and optional presubmission inquiry) for a Cancer Cell (Cell Press) submission — framing significance, fit, novelty, and suggested/excluded reviewers. It writes the letter; it does not edit the manuscript itself.

SKILL.md

4.6 KB, as published. Nobody here has run it

Cover Letter & Presubmission Inquiry (cc-cover-letter)

When to trigger

  • Preparing the cover letter for full submission
  • Considering a Cell Press presubmission inquiry to gauge fit
  • Need to suggest or exclude reviewers
  • Need to state exclusivity / prior-communication / preprint status

Presubmission inquiry (optional, fit-saving)

Cell Press allows a short editorial inquiry before full submission. Use it to test fit when uncertain:

  • 1 short paragraph: the central finding and why it suits Cancer Cell.
  • Attach the abstract/Summary and a key figure or graphical abstract.
  • Ask directly whether the editors would welcome a full submission.

Cover-letter structure (full submission)

  1. Opening — addressed to the editor; manuscript title and that it is submitted to Cancer Cell.
  2. The advance in 2–3 sentences — the mechanism and the translational relevance, in plain language a broad cancer audience grasps.
  3. Why Cancer Cell — fit with the journal's mechanism + translational scope and interest to its readership.
  4. Evidence strength — note the orthogonal validation (cells + in vivo + human/patient data) that supports the claim.
  5. Novelty vs. closest prior work — one sentence on what is new and why now.
  6. Declarations — original, not under consideration elsewhere; preprint status; any prior editorial communication or transfer; related manuscripts in press.
  7. Reviewer suggestions / exclusions — see below.
  8. Close — corresponding author and contact.

Reviewers

  • Suggest several genuine experts (different institutions; no recent collaborators, co-authors, mentors/mentees, or same-institution colleagues — avoid conflicts).
  • Exclude direct competitors only with a brief, professional reason.
  • Keep suggestions current and reachable; do not pad with marginal names.

Calibrate the pitch

  • Match claims to evidence exactly as in the manuscript (no extra promises in the letter).
  • Lead with the discovery; do not bury it under background.
  • Keep it to roughly one page; respectful, specific, not promotional fluff.

Checklist

  • Title and target journal stated up front
  • Advance summarized in 2–3 plain sentences (mechanism + translational point)
  • Explicit "why Cancer Cell" fit paragraph
  • Orthogonal validation noted as evidence strength
  • Novelty vs. closest prior work stated
  • Originality / preprint / prior-communication declarations included
  • Suggested reviewers (conflict-free) and any exclusions with reasons
  • Corresponding author + contact; ~1 page; claims match the paper

Anti-patterns

  • Overstating impact beyond what the manuscript shows
  • A generic letter that never says why Cancer Cell specifically
  • Suggesting close collaborators or same-institution reviewers
  • Excluding many competitors without justification (reads defensively)
  • Omitting preprint or prior-communication disclosure
  • A multi-page essay restating the abstract

Cover-letter pass for Cancer Cell

Use this as a second-pass capability check. First lock the cancer context, mechanism, model system, validation chain, and translational boundary; then test whether the manuscript addresses cancer-biology reviewers who expect mechanistic oncology, translational relevance, and strong multi-modal validation.

  • Primary move: Make the letter a routing document: contribution, fit, compliance, conflicts, and the single reason the editor should send the paper to review.
  • Decision ledger: return claim / evidence / blocker / next edit rows so the next pass can patch the manuscript directly.
  • Neighbor test: compare against Cell for broader biology, Nature Cancer for oncology breadth, Clinical Cancer Research for clinical translation; if the neighboring outlet has the stronger audience claim, recommend re-routing before polishing.
  • Verification floor: before submission-ready advice, re-open resources/official-source-map.md for volatile rules and name the one unresolved fact that could change the recommendation.

Output format

【Inquiry or full submission】which
【Advance (2–3 sentences)】...
【Why Cancer Cell】...
【Evidence strength line】orthogonal validation: ...
【Declarations】originality / preprint / prior comms
【Reviewers】suggested (conflict-free): [...]; excluded: [...]
【Length / tone】~1 page, claims match paper? Y/N
【Next step】cc-submission

Keep looking

Skills are one crate of 328,083. Ordering is by how many stacks a row turns up in, so the top of any crate is what has actually been picked rather than what has the most stars.